Multi-Centre, Prospective, Open Label, Randomized Trial to Assess the Efficacy and Safety of Moxifloxacin Versus Levofloxacin Plus Metronidazole in the Treatment of Community-Acquired Pneumonia With Aspiration Factors.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Levofloxacin; Metronidazole; Moxifloxacin
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Therapeutic Use
- 11 Mar 2009 Biomarkers information updated
- 28 Jan 2009 Actual initiation date (Sep 2008) added as reported by ClinicalTrials.gov.
- 28 Jan 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.